astilbin has been researched along with alpha-synuclein in 1 studies
| Studies (astilbin) | Trials (astilbin) | Recent Studies (post-2010) (astilbin) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 142 | 0 | 91 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cheng, K; Cui, C; Jia, XB; Qiao, CM; Shen, YQ; Sun, MF; Xu, YD; Yang, XS; Zhang, PH; Zhou, ZL; Zhu, YL | 1 |
1 other study(ies) available for astilbin and alpha-synuclein
| Article | Year |
|---|---|
Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Astrocytes; Disease Models, Animal; Dopaminergic Neurons; Down-Regulation; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Substantia Nigra | 2019 |